Effects of utero-ovarian anastomoses on basal follicle-stimulating hormone level change after uterine artery embolization with tris-acryl gelatin microspheres

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 6, 2006, Pages 965-971

  Kim, Hyun S ^a   Tsai, Jason ^a   Lee, Judy M ^a   Vang, Russell ^a   Griffith, John G ^a   Wallach, Edward E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GELATIN; MICROSPHERE;

ADULT; ANASTOMOSIS; ARTERIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE ARTERY; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA;

ACRYLIC RESINS; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIOVENOUS ANASTOMOSIS; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLICLE STIMULATING HORMONE; GELATIN; HUMANS; LEIOMYOMA; MIDDLE AGED; OVARY; PREMENOPAUSE; TREATMENT OUTCOME; UTERINE NEOPLASMS; UTERUS;

EID: 33748175900     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000220425.23309.15     Document Type: Article

References (37)

1. Goodwin S, McLucas B, Lee M, et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol 1999; 10:1159-1165.
2. Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology 2000; 215:428-431.
3. Ravina J, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346:671-672.
4. Spies JB, Ascher SA, Roth AR, et al. Uterine artery embolization for leiomyomata. Obstet Gynecol 2001; 98:29-34.
5. Spies JB, Roth AR, Gonsalves SM, et al. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol 2001; 12:437-442.
6. Worthington-Kirsch R, Popky G, Hutchins FJ. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 1998; 208:625-629.
7. Ravina J, Vigneron N, Aymard A, et al. Pregnancy after embolization of uterine myoma: report of 12 cases. Fertil Steril 2000; 73:1241-1243.
8. Pron G, Mocarski E, Bennett J, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario Multicenter Trial. Obstet Gynecol 2005; 105:67-76.
9. Chrisman HB, Saker MB, Ryu RK, et al. The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol 2000; 11:699-703.
10. Amato P, Roberts A. Transient ovarian failure: a complication of uterine artery embolization. Fertil Steril 2001; 75:438-439.
11. Payne JF, Robboy SJ, Haney AF. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet Gynecol 2002; 100:883-886.
12. Ryu RK, Chrisman HB, Omary RA, et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation. J Vasc Interv Radiol 2001; 12:1071-1074.
13. Ryu RK, Siddiqi A, Omary RA, et al. Sonography of delayed effects of uterine artery embolization on ovarian arterial perfusion and function. AJR Am J Roentgenol 2003; 181:89-92.
14. Tulandi T, Sammour A, Valenti D, et al. Ovarian reserve after uterine artery embolization for leiomyomata. Fertil Steril 2002; 78:197-198.
15. Kozik W. Arterial vasculature of ovaries in women of various ages in light of anatomic, radiologic and microangiographic examinations. Ann Acad Med Stetin 2000; 46:25-34.
16. Kozik W, Czerwinski F, Pilarczyk K, et al. Arteries of the hilum and parenchymal part of the ovary in reproductive age in microangiographic studies. Ginekol Pol 2002; 73:1173-1178.
17. Karlsson S, Jonsson K. Angiography of the ovarian artery in adnexal lesions. Acta Radiol Diagn 1980; 21:739-746.
18. Karlsson S, Persson P. Angiography in uterine and adnexal tumors. Acta Radiol Diagn 1980; 21:11-20.
19. Razavi MK, Wolanske KA, Hwang GL, et al. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology 2002; 224:707-712.
20. Goodwin SC, Bonilla SM, Sacks D, et al. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol 2001; 12:1011-1020.
21. Burger HG. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition: an analysis of FSH, oestradiol and inhibin. Eur J Endocrinol 1994; 130:38-42.
22. Burger HG, Dudley EC, Robertson DM, et al. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002; 57:257-275.
23. Robertson DM, Burger HG. Reproductive hormones: ageing and the perimenopause. Acta Obstet Gynecol Scand 2002; 81:612-616.
24. Ahmad A, Qadan L, Hassan N, et al. Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J Vasc Interv Radiol 2002; 13:1017-1020.
25. Healey S, Buzaglo K, Seti L, et al. Ovarian function after uterine artery embolization and hysterectomy. J Am Assoc Gynecol Laparosc 2004; 11:348-352.
26. Tropeano G, Di Stasi C, Litwicka K, et al. Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil Steril 2004; 81:1055-1061.
27. Chiesa AG, Hart WR. Uterine artery embolization of leiomyomas with trisacryl gelatin microspheres (TGM): pathologic features and comparison with polyvinyl alcohol emboli. Int J Gynecol Pathol 2004; 23:386-392.
28. Fogt F, Hinds N, Zimmerman RL. Histologic features of uterine leiomyomata treated with microsphere embolization. Obstet Gynecol 2003; 102:600-602.
29. Pelage JP, Le Dref O, Beregi JP, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 2003; 14:15-20.
30. Colgan T, Pron G, Mocarski E, et al. Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas. Am J Surg Pathol 2003; 27:167-177.
31. McCluggage WG, Ellis PK, McClure N, et al. Pathologic features of uterine leiomyomas following uterine artery embolization. Int J Gynecol Pathol 2000; 19:342-347.
32. Siskin GP, Dowling K, Virmani R, et al. Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model. J Vasc Interv Radiol 2003; 14:89-98.
33. Danforth DR, Arbogast LK, Mroueh J, et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 1998; 70:119-123.
34. Eldar-Geva T, Ben-Chetrit A, Spitz IM, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005; 20:3178-3183.
35. Overlie I, Morkrid L, Andersson AM, et al. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition. Acta Obstet Gynecol Scand 2005; 84:281-285.
36. Themmen AP. Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 2005; 34:18-21.
37. Pelage JP, Guaou NG, Jha RC, et al. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004; 230:803-809.